Healthcare Analysis of the European Bipolar-disorder Therapeutics Market

Improving New Drug Formulations and Strong Product Pipelines Expected to Restore Growth beyond 2013

INDUSTRY
Healthcare

RELEASE DATE
18-May-2012
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
M855-01-00-00-00
SKU
HC01978-EU-MR_07214
Yes
SHARE

Analysis of the European Bipolar-disorder Therapeutics Market
Published on: 18-May-2012 | SKU: HC01978-EU-MR_07214

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatment—atypical antipsychotics, mood stabilisers and anti-depressants—with a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.

Summary of the European Bipolar-disorder Therapeutics Market

  • Executive Summary

Introduction to the European Bipolar-disorder Therapeutics Market

  • Research Scope and Objectives
  • Bipolar-disorder Disease Segmentation
  • Geographic Scope

Overview of the European Bipolar-disorder Therapeutics Market

  • Market Overview

Introduction to Bipolar-disorder Disease

  • Bipolar Disorder- Definition
  • Signs and Symptoms
  • Diagnosis
  • Diagnostic Scales for Bipolar-disorder
  • Risk Factors

Management of Bipolar Disorder - Drugs Used and Treatment Regimen

  • Classification of Drugs
  • Treatment of Acute Mania
  • Treatment of Depression
  • Treatment of Mixed Episodes and Maintenance Phase
  • Psychological Intervention

Epidemiology of Bipolar Disorder in Europe

  • Demographics by Country
  • Prevalence of Mood Disorders in Europe
  • Prevalence and Mortality Rates of Bipolar Disorder by Age and Gender
  • Lifetime Prevalence of Co-morbidities with Bipolar Disorder
  • Bipolar-disorder Treatment Statistics in Europe

Industry Challenges, Market Drives and Restraints of the European Bipolar-disorder Therapeutics Market

  • Industry Challenges- Impact and Duration
  • Market Drivers and Restraints
  • Impact Mapping of Drivers and Restraints

Market Engineering Measurements and Revenue Forecasts

  • Market Engineering Measurements
  • Forecast Assumptions
  • Total Bipolar-disorder Therapeutics Market Revenue Forecast
  • Total Bipolar-disorder Therapeutics Market Revenue Forecast Discussion
  • Bipolar-disorder Therapeutics Market Per Cent of Revenue by Country

Analysis of the Competitive Landscape of the European Bipolar-disorder Therapeutics Market

  • Competitive Structure
  • Competitive Analysis: Profiling of Selected Key Market Participants
  • Competitive Analysis: Promising Companies in the Future
  • Bipolar-disorder Therapeutics Market Competitive Landscape

Analysis of the Marketed Products for Bipolar Disorder

  • Marketed Product Analysis — Bipolar-disorder Medication
  • Marketed Product Analysis — Key Patent Expiries

Analysis of Potential Bipolar Drug Candidates in Pipeline

Cost Analysis of the European Bipolar-disorder Therapeutics Market

Regulatory Analysis of the European Bipolar-disorder Therapeutics Market

Analysis of the Atypical Antipsychotic Drugs Segment for Bipolar Disorder

Analysis of the Mood-stabilising Drugs Segment for Bipolar Disorder

Analysis of the Anti-depressant Drugs Segment for Bipolar Disorder

Germany Bipolar-disorder Therapeutics Market

France Bipolar-disorder Therapeutics Market

The United Kingdom Biolar-disorder Therapeutics Market

Italy Bipolar-disorder Therapeutics Market

Spain Bipolar-disorder Therapeutics Market

Conclusions and Implications

Summary of Major Findings of the European Bipolar-disorder Therapeutics Market

Support Databases


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatmentatypical antipsychotics, mood stabilisers and anti-depressantswith a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Aiswariya Chidambaram
Industries Healthcare
WIP Number M855-01-00-00-00
Is Prebook No

Analysis of the European Bipolar-disorder Therapeutics Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01978-EU-MR_07214